This is a discussion on Information for Healthcare Professionals: New Safety Information for Colchicine (marketed as Colcrys) within the FDA News forum, part of the Industry News and Updates category; More......
|
|||||||
| Register | Help | Members List | Mark Forums Read |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Information for Healthcare Professionals: Varenicline (marketed as Chantix) and Bupropion (marketed as Zyban, Wellbutrin | industry_news | FDA News | 0 | 07-01-2009 01:24 PM |
| Information for Healthcare Professionals: Cefepime (marketed as Maxipime) | industry_news | FDA News | 0 | 06-17-2009 12:00 PM |
| FDA issues Information for Healthcare Professionals for Insulin Pens | industry_news | FDA News | 0 | 03-19-2009 01:21 PM |
| Information for Healthcare Professionals Phenytoin and Fosphenytoin Sodium | industry_news | FDA News | 0 | 11-24-2008 05:31 PM |
| Covidien and Mallinckrodt Inc. inform healthcare professionals of important new safety information in prescribing Phosph | industry_news | FDA News | 0 | 09-18-2008 06:36 PM |